1. NF-κB Signaling.
- Author
-
EGAN, LAURENCE J. and TORUNER, MURAT
- Subjects
PROTEINS ,THERAPEUTICS ,INFLAMMATORY bowel diseases ,TRANSCRIPTION factors ,CELL death ,APOPTOSIS - Abstract
The transcription factor, nuclear factor-κB (NF-κB), is a dominant regulator of the expression of hundreds of genes, many of which play important roles in the regulation of inflammation and programmed cell death (apoptosis). Since the discovery of NF-κB in the mid 1980s, this transcription factor has been the subject of intense investigation. Excess or inappropriate activation of NF-κB has been observed in human inflammatory bowel disease and in a host of other inflammatory diseases and type of cancer. Functional studies in animals have shed light on the role of NF-κB in broader pathophysiological contexts. From such studies, it has become quite clear that NF-κB plays unique and distinct functions in different cell types. Because of the importance of NF-κB in signaling inflammation, and in inhibiting programmed cell death, many pharmaceutical companies are developing small-molecule inhibitors of this pathway. In this article, we evaluate the relative pros and cons of blocking NF-κB as a therapeutic approach for inflammatory bowel disease. On the basis of the results of studies in animals that have primarily used genetic approaches to inhibit NF-κB activity, we suggest that there are certain niche indications for blocking NF-κB in inflammatory bowel disease that offer particular promise. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF